Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleThe MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide.AuthorsRapkins, Robert W.; Fan Wang; Nguyen, HuyTram N.; Cloughesy, Timothy F.; Lai, Albert; Ha, Wendy; Nowak, Anna K.; Hitchins, Megan P.; McDonald, Kerrie L.PublicationNeuro-Oncology, 2015, Vol 17, Issue 12, p1589ISSN1522-8517Publication typeArticleDOI10.1093/neuonc/nov064